PAVmed (PAVM) Retained Earnings (2015 - 2026)

PAVmed has reported Retained Earnings for 12 years, with the latest figure at $295.7 million in Q2 2026.

• On a quarterly basis, Retained Earnings rose 12.21% year-over-year to $295.7 million in Q2 2026; TTM through Jun 2026 was $295.7 million, a 12.21% increase from a year earlier, with the FY2025 full-year figure at $268.0 million, up 205.12% from the prior year.
• Retained Earnings was $295.7 million for Q2 2026 at PAVmed, up from $268.0 million in the prior quarter.
• The five-year high for Retained Earnings was $295.7 million in Q2 2026, with the low at -$320.6 million in Q2 2024.
• Average Retained Earnings over 5 years is -$14.3 million, with a median of -$14.2 million recorded in 2022.
• The sharpest annual moves came in 2023 and 2025: Retained Earnings plunged 229.98% in 2023, then surged 205.12% in 2025.
• Over 5 years, Retained Earnings stood at -$228.2 million in 2022, then declined by 29.04% to -$294.4 million in 2023, then climbed by 13.4% to -$255.0 million in 2024, then soared by 205.12% to $268.0 million in 2025, then grew by 10.33% to $295.7 million in 2026.
• The last three Retained Earnings figures came in at $295.7 million (Q2 2026), $268.0 million (Q4 2025), and $265.3 million (Q3 2025), per Business Quant data.